State Of Wisconsin Investment Board Gossamer Bio, Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $10,389 - $21,442	-1,441 Reduced 2.76%	50,825 $609,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $143,482 - $239,618	-24,034 Reduced 31.5%	52,266 $437,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $27,616 - $35,008	-3,200 Reduced 4.03%	76,300 $706,000
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $124,300 - $162,250	11,000 Added 16.06%	79,500 $987,000
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $21,896 - $36,754	2,300 Added 3.47%	68,500 $890,000
Q1 2020 May 06, 2020	BUY	$8.0 - $15.48 $289,600 - $560,376	36,200 Added 120.67%	66,200 $672,000
Q3 2019 Nov 12, 2019	BUY	$16.02 - $22.47 $222,678 - $312,333	13,900 Added 86.34%	30,000 $504,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $259,532 - $368,529	16,100 New	16,100 $357,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $83.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.